NCT04471844: An ongoing trial by NovoCure Ltd.
This trial is ongoing. It must report results 9 months, 1 week from now.
Full data
| Full entry on ClinicalTrials.gov | NCT04471844 |
|---|---|
| Title | EF-32: Pivotal, Randomized, Open-Label Study of Optune® (Tumor Treating Fields, 200kHz) Concomitant With Radiation Therapy and Temozolomide for the Treatment of Newly Diagnosed Glioblastoma |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 8, 2020 |
| Completion date | Feb. 19, 2026 |
| Required reporting date | Feb. 19, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | May 14, 2026 |
| Days late | None |